Issue 2/2021
Content (25 Articles)
Gastric equivalent of the ‘Holy Plane’ to standardize the surgical concept of stomach cancer to mesogastric excision: updating Jamieson and Dobson’s historic schema
Hisashi Shinohara, Yasunori Kurahashi, Yoshinori Ishida
Gastric cancer is highly prevalent in Lynch syndrome patients with atrophic gastritis
Hourin Cho, Masayoshi Yamada, Shigeki Sekine, Noriko Tanabe, Mineko Ushiama, Makoto Hirata, Gakuto Ogawa, Masahiro Gotoh, Teruhiko Yoshida, Takaki Yoshikawa, Yutaka Saito, Aya Kuchiba, Ichiro Oda, Kokichi Sugano
The potential role of nontyphoidal salmonellosis in gastric cancer: a nationwide matched cohort study
Renin Chang, James Cheng-Chung Wei, Mei-Chen Lin, Yao-Min Hung
Promising aberrant DNA methylation marker to predict gastric cancer development in individuals with family history and long-term effects of H. pylori eradication on DNA methylation
Hee Jin Kim, Nayoung Kim, Hyoung Woo Kim, Ji Hyun Park, Cheol Min Shin, Dong Ho Lee
Tumor suppressor ATP4B serve as a promising biomarker for worsening of gastric atrophy and poor differentiation
Yuanming Pan, Xin Wang, Yuqi He, Shuye Lin, Min Zhu, Yangjie Li, Jianxun Wang, Jiheng Wang, Xianzong Ma, Junfeng Xu, Lang Yang, Guibin Yang, Jiaqiang Huang, Youyong Lu, Jianqiu Sheng
Expression of the immune checkpoint molecule V-set immunoglobulin domain-containing 4 is associated with poor prognosis in patients with advanced gastric cancer
So-Woon Kim, Jin Roh, Hye Seung Lee, Min-Hee Ryu, Young-Soo Park, Chan-Sik Park
MAGEA10 expression is a predictive marker of early hepatic recurrence after curative gastrectomy for gastric and gastroesophageal junction cancer
Keiichi Fujiya, Masanori Terashima, Keiichi Ohshima, Daisuke Aizawa, Takashi Sugino, Masakuni Serizawa, Kenichi Nakamura, Takeshi Nagashima, Keiichi Hatakeyama, Kenichi Urakami, Yasuto Akiyama, Yasuhiro Tsubosa, Yuko Kitagawa, Ken Yamaguchi
Apatinib exhibits synergistic effect with pyrotinib and reverses acquired pyrotinib resistance in HER2-positive gastric cancer via stem cell factor/c-kit signaling and its downstream pathways
Beibei Su, Tingting Huang, Yu Jin, Han Yin, Hong Qiu, Xianglin Yuan
Histological diversity and molecular characteristics in gastric cancer: relation of cancer stem cell-related molecules and receptor tyrosine kinase molecules to mixed histological type and more histological patterns
Kazuhiro Sentani, Takeharu Imai, Go Kobayashi, Tetsutaro Hayashi, Naomi Sasaki, Naohide Oue, Wataru Yasui
Molecular alterations in gastric cancer and the surrounding intestinal metaplastic mucosa: an analysis of isolated glands
Ryo Sugimoto, Wataru Habano, Naoki Yanagawa, Risaburo Akasaka, Yosuke Toya, Akira Sasaki, Takayuki Matsumoto, Tamotsu Sugai
Early Gastric Cancer: identification of molecular markers able to distinguish submucosa-penetrating lesions with different prognosis
Chiara Molinari, Gianluca Tedaldi, Francesca Rebuzzi, Paolo Morgagni, Laura Capelli, Sara Ravaioli, Maria Maddalena Tumedei, Emanuela Scarpi, Anna Tomezzoli, Riccardo Bernasconi, Maria Raffaella Ambrosio, Alessia D’Ignazio, Leonardo Solaini, Francesco Limarzi, Giorgio Ercolani, Giovanni Martinelli, Paola Ulivi, Luca Saragoni
SHARPIN stabilizes β-catenin through a linear ubiquitination-independent manner to support gastric tumorigenesis
Liang Zhang, Qin Liu, Ke-wei Liu, Zhong-yi Qin, Guang-xi Zhu, Li-ting Shen, Ni Zhang, Bi-ying Liu, Lin-rong Che, Jin-yang Li, Tao Wang, Liang-zhi Wen, Kai-jun Liu, Yan Guo, Xin-ru Yin, Xing-wei Wang, Zhi-hua Zhou, Hua-liang Xiao, You-hong Cui, Xiu-wu Bian, Chun-hui Lan, Dongfeng Chen, Bin Wang
Diagnostic performance in gastric cancer is higher using endocytoscopy with narrow-band imaging than using magnifying endoscopy with narrow-band imaging
Yusuke Horiuchi, Toshiaki Hirasawa, Naoki Ishizuka, Hiroyuki Hatamori, Yohei Ikenoyama, Junki Tokura, Mitsuaki Ishioka, Yoshitaka Tokai, Ken Namikawa, Shoichi Yoshimizu, Akiyoshi Ishiyama, Toshiyuki Yoshio, Tomohiro Tsuchida, Junko Fujisaki
Docetaxel plus S-1 versus cisplatin plus S-1 in unresectable gastric cancer without measurable lesions: a randomized phase II trial (HERBIS-3)
Yukinori Kurokawa, Jin Matsuyama, Kazuhiro Nishikawa, Atsushi Takeno, Yutaka Kimura, Kazumasa Fujitani, Ryohei Kawabata, Yoichi Makari, Tetsuji Terazawa, Hisato Kawakami, Daisuke Sakai, Toshio Shimokawa, Taroh Satoh
Clinical outcomes of endoscopic resection for undifferentiated intramucosal early gastric cancer larger than 2 cm
Hyo-Joon Yang, Su Youn Nam, Byung-Hoon Min, Ji Yong Ahn, Jae-Young Jang, Jung Kim, Jie-Hyun Kim, Wan-Sik Lee, Bong Eun Lee, Moon Kyung Joo, Jae Myung Park, Woon Geon Shin, Hang Lak Lee, Tae-Geun Gweon, Moo In Park, Jeongmin Choi, Chung Hyun Tae, Young-Il Kim, Il Ju Choi
External validity of docetaxel triplet trials in advanced gastric cancer: are there patients who still benefit?
Paula Jimenez-Fonseca, Alberto Carmona-Bayonas, Eva Martínez de Castro, Ana Custodio, Carles Pericay Pijaume, Raquel Hernandez, Gema Aguado, Natalia Castro Unanua, Juana María Cano, Flora López, Marcelo Garrido, Ana Fernández Montes, Laura Visa, Manuel Sánchez Cánovas, María Luisa Limón, Nieves Martínez Lago, Paola Pimentel, Alicia Hurtado, Aitor Azkárate, Federico Longo, Marc Diez, Aranzazu Arias-Martinez, Tamara Sauri, Alfonso Martín Carnicero, Monserrat Mangas, Marta Martín Richard, Mónica Granja, Avinash Ramchandani, Carolina Hernández Pérez, Paula Cerdá, Aitziber Gil-Negrete, Mariona Calvo, Rosario Vidal Tocino, Javier Gallego
Prognostic significance of sarcopenia in microsatellite-stable gastric cancer patients treated with programmed death-1 inhibitors
Yeun-Yoon Kim, Jeeyun Lee, Woo Kyoung Jeong, Seung Tae Kim, Jae-Hun Kim, Jung Yong Hong, Won Ki Kang, Kyoung-Mee Kim, Insuk Sohn, Dongil Choi
Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial
Kazumasa Fujitani, Kohei Shitara, Atsuo Takashima, Keisuke Koeda, Hiroki Hara, Norisuke Nakayama, Shuichi Hironaka, Kazuhiro Nishikawa, Yutaka Kimura, Kenji Amagai, Hisashi Hosaka, Yoshito Komatsu, Ken Shimada, Ryohei Kawabata, Hideki Ohdan, Yasuhiro Kodera, Masato Nakamura, Takako Eguchi Nakajima, Yoshinori Miyata, Toshikazu Moriwaki, Tetsuya Kusumoto, Kazuo Nishikawa, Kazuhiro Ogata, Masashi Shimura, Satoshi Morita, Wasaburo Koizumi
Correction to: Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial
Kazumasa Fujitani, Kohei Shitara, Atsuo Takashima, Keisuke Koeda, Hiroki Hara, Norisuke Nakayama, Shuichi Hironaka, Kazuhiro Nishikawa, Yutaka Kimura, Kenji Amagai, Hisashi Hosaka, Yoshito Komatsu, Ken Shimada, Ryohei Kawabata, Hideki Ohdan, Yasuhiro Kodera, Masato Nakamura, Takako Eguchi Nakajima, Yoshinori Miyata, Toshikazu Moriwaki, Tetsuya Kusumoto, Kazuo Nishikawa, Kazuhiro Ogata, Masashi Shimura, Satoshi Morita, Wasaburo Koizumi
A nonrandomized, single-arm confirmatory trial of expanded endoscopic submucosal dissection indication for undifferentiated early gastric cancer: Japan Clinical Oncology Group study (JCOG1009/1010)
Kohei Takizawa, Hiroyuki Ono, Noriaki Hasuike, Atsuo Takashima, Keiko Minashi, Narikazu Boku, Ryoji Kushima, Hiroshi Katayama, Gakuto Ogawa, Haruhiko Fukuda, Junko Fujisaki, Ichiro Oda, Tomonori Yano, Shinichiro Hori, Hisashi Doyama, Kingo Hirasawa, Yoshinobu Yamamoto, Ryu Ishihara, Satoshi Tanabe, Yasumasa Niwa, Masahiro Nakagawa, Masanori Terashima, Manabu Muto
Gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer (JCOG0501): an open-label, phase 3, randomized controlled trial
Yoshiaki Iwasaki, Masanori Terashima, Junki Mizusawa, Hiroshi Katayama, Kenichi Nakamura, Hitoshi Katai, Takaki Yoshikawa, Seiji Ito, Masahide Kaji, Yutaka Kimura, Motohiro Hirao, Makoto Yamada, Akira Kurita, Masakazu Takagi, Sang-Woong Lee, Akinori Takagane, Hiroshi Yabusaki, Jun Hihara, Narikazu Boku, Takeshi Sano, Mitsuru Sasako
Multi-institutional development and validation of a nomogram to predict recurrence after curative resection of gastric neuroendocrine/mixed adenoneuroendocrine carcinoma
Hualong Zheng, YaJun Zhao, Qingliang He, Hankun Hao, Yantao Tian, Bingbing Zou, Lixin Jiang, Xiantu Qiu, Yanbing Zhou, Zhi Li, Yanchang Xu, Gang Zhao, Fangqin Xue, Shuliang Li, Weihua Fu, Yongxiang Li, Xiaojun Zhou, Yong Li, Zhenggang Zhu, Jinping Chen, Zekuan Xu, Lisheng Cai, En Li, Honglang Li, Jianwei Xie, Chaohui Zheng, Jun Lu, Ping Li, Changming Huang
Assessment of diagnostic value of fluorescent lymphography-guided lymphadenectomy for gastric cancer
Minoa K. Jung, Minah Cho, Chul Kyu Roh, Won Jun Seo, Seohee Choi, Taeil Son, Hyoung-Il Kim, Woo Jin Hyung
Association of surgeon and hospital volume with postoperative mortality after total gastrectomy for gastric cancer: data from 71,307 Japanese patients collected from a nationwide web-based data entry system
Masaaki Iwatsuki, Hiroyuki Yamamoto, Hiroaki Miyata, Yoshihiro Kakeji, Kazuhiro Yoshida, Hiroyuki Konno, Yasuyuki Seto, Hideo Baba
Multicenter prospective trial of total gastrectomy versus proximal gastrectomy for upper third cT1 gastric cancer
Makoto Yamasaki, S. Takiguchi, T. Omori, M. Hirao, H. Imamura, K. Fujitani, S. Tamura, Y. Akamaru, K. Kishi, J. Fujita, T. Hirao, K. Demura, J. Matsuyama, A. Takeno, C. Ebisui, K. Takachi, O. Takayama, H. Fukunaga, K. Okada, S. Adachi, S. Fukuda, N. Matsuura, T. Saito, T. Takahashi, Y. Kurokawa, M. Yano, H. Eguchi, Y. Doki